The market for prostate cancer treatment is actively growing, as the disease is one of the most common and most fatal cancers among all races of men in the U.S. Within the next several years, it's likely that we'll see a plethora of new options for treating prostate cancer coming to the market.

With breast cancer as the most commonly diagnosed cancer among women in the United States, biotechnology and pharmaceutical companies are investing time, energy and huge amounts of money into crafting innovative new breast cancer diagnosis and treatment options.